Company
4DMedical Limited
Headquarters: Melbourne, VIC, Australia
Employees: 95
CEO: Dr. Andreas Fouras M.A.I.C.D., Ph.D.
Market Cap
A$225.8 Million
AUD as of July 1, 2024
US$150.4 Million
4DMedical Limited Categories
Australia Healthcare Medical DevicesAustralia Healthcare Australia Medical Devices
Top Competitors by Market Capitalization
Industry: Medical Devices
| Company | Market Cap (USD) |
|---|---|
| Abbott | $178.02 B |
| Stryker Corporation | $126.48 B |
| Boston Scientific Corporation | $112.32 B |
| Medtronic | $98.95 B |
| Edwards Lifesciences Corporation | $55.63 B |
Sector:
| Company | Market Cap (USD) |
|---|---|
| Lilly | $808.65 B |
| Novo Nordisk | $622.07 B |
| UnitedHealth Group | $450.89 B |
| Johnson & Johnson | $350.63 B |
| Merck | $318.75 B |
Detailed Description
4DMedical Limited operates as a medical technology company in Australia and the United States. It commercializes XV Technology, a four-dimensional lung imaging technology that utilizes proven and patented mathematic models and algorithms to convert X-ray scans into quantitative data to enhance the capacity of physicians to manage patients with respiratory diseases and diseases of the lung. The company is also developing VQ (Perfusion), a diagnostic to scan and measure ventilation and perfusion; and Contrast Free Pulmonary Angiography (CFPA) products, as well as small animal ventilators and preclinical scanners. 4Dmedical Limited partners with the University of Miami Health System to establish the functional lung imaging research program. The company was incorporated in 2012 and is based in Carlton, Australia.
Top 1-year algo backtest: +265.99%
$10,000 in October 2023 would now be $36,599 by following this algorithm daily at market close.
Use AI to boost your investing & swing trading, now!
Try Disfold DeepFinance FREE
Stocks & Indices
4DMedical Limited has the following listings and related stock indices.
Stock: ASX: 4DX wb_incandescent